These new potential treatments for advanced head and neck cancer include new applications of anti-PD-1 monoclonal antibodies (described in Section 3), alternative checkpoint targets, combination strategies for immunotherapies and other treatments, oncolytic virus therapies, therapeutic cancer vaccines, and adoptive cell therapies. Here, PDCD1 is linked to head and neck cancer.